401 - 450 of 6509 Results
Title
Year
-
OPENTitle: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI databaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 34End Page: 37Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007Best OA location URL: https://repositorio.uca.edu.ar/handle/123456789/11625Citation Count: 21
-
OPENTitle: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 133End Page: 137Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002Best OA location URL: http://www.prd-journal.com/article/S1353802020309007/pdfCitation Count: 7
- Plasma NfL, clinical subtypes and motor progression in Parkinson's disease2021OPENTitle: Plasma NfL, clinical subtypes and motor progression in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 41End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.016Citation Count: 58
-
OPENTitle: Consistent skin α-synuclein positivity in REM sleep behavior disorder – A two center two-to-four-year follow-up studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 108End Page: 113Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.007Best OA location URL: http://hdl.handle.net/11380/1251595Citation Count: 35
-
OPENTitle: A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 128End Page: 133Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.013Best OA location URL: http://www.prd-journal.com/article/S1353802021002625/pdfCitation Count: 27
-
OPENTitle: Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experienceJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 66End Page: 76Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.018Best OA location URL: http://www.prd-journal.com/article/S1353802021003126/pdfCitation Count: 18
-
OPENTitle: Predicting Parkinson's disease trajectory using clinical and neuroimaging baseline measuresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 85Issue #:Start Page: 44End Page: 51Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.026Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8127393Citation Count: 25
-
OPENTitle: A metabolomic study of cervical dystoniaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 98End Page: 103Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7856090Citation Count: 10
-
OPENTitle: How firms undertake organizational changes to shift to more-exploratory strategies: A process perspectiveJournal Name: Research PolicyPublisher: Elsevier BVVol: 50Issue #: 1Start Page: 104118End Page: 104118Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.respol.2020.104118Best OA location URL: https://minesparis-psl.hal.science/hal-02943926Citation Count: 26
-
OPENTitle: Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosisJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 84Issue #:Start Page: 343End Page: 351Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2021.06.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8355084Citation Count: 7
-
OPENTitle: Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 648417End Page: 648417Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.648417Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.648417/pdfCitation Count: 11
-
OPENTitle: The mechanisms of smell loss after SARS-CoV-2 infectionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 9Start Page: 693End Page: 695Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00202-7Best OA location URL: http://www.thelancet.com/article/S1474442221002027/pdfCitation Count: 22
-
OPENTitle: Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 203End Page: 212Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30449-xBest OA location URL: http://hdl.handle.net/2445/214932Citation Count: 323
-
OPENTitle: High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosisJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 38Issue #:Start Page: 100988End Page: 100988Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.eclinm.2021.100988Best OA location URL: https://doi.org/10.1016/j.eclinm.2021.100988Citation Count: 125
-
OPENTitle: Generation of human midbrain organoids from induced pluripotent stem cellsJournal Name: MNI Open ResearchPublisher: F1000 Research LtdVol: 3Issue #:Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.12688/mniopenres.12816.2Best OA location URL: https://doi.org/10.12688/mniopenres.12816.2Citation Count: 17
-
OPENTitle: Assessing the Quality and Reliability of COVID-19 Information on Patient Organization WebsitesJournal Name: Frontiers in CommunicationPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcomm.2021.716683Best OA location URL: https://www.frontiersin.org/journals/communication/articles/10.3389/fcomm.2021.716683/pdfCitation Count: 8
-
OPENTitle: Vascular risk profile and white matter hyperintensity volume among Mexican Americans and non‐Hispanic Whites: The HABLE studyJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 14Issue #: 1Start Page: e12263End Page: e12263Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/dad2.12263Best OA location URL: https://escholarship.org/uc/item/6sd39197Citation Count: 17
-
OPENTitle: A novel process driving Alzheimer's disease validated in a mouse model: Therapeutic potentialJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page: e12274End Page: e12274Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/trc2.12274Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/trc2.12274Citation Count: 25
-
OPENTitle: Gastric acid suppressants and cognitive decline in people with or without cognitive impairmentJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page: e12243End Page: e12243Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12243Best OA location URL: https://doi.org/10.1002/trc2.12243Citation Count: 13
-
OPENTitle: A Collaboration for Guiding the Rational Design of Multielement Solid CatalystsJournal Name: Angewandte Chemie International EditionPublisher: WileyVol: 62Issue #: 7Start Page: e202216327End Page: e202216327Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/anie.202216327Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.202216327Citation Count: 0
-
OPENTitle: Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core studyJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page: e12329End Page: e12329Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12329Best OA location URL: https://doi.org/10.1002/trc2.12329Citation Count: 17
-
OPENTitle: A Collaboration for Guiding the Rational Design of Multielement Solid CatalystsJournal Name: Angewandte ChemiePublisher: WileyVol: 135Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ange.202216327Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ange.202216327Citation Count: 0
- Tracking cortical excitability dynamics with transcranial magnetic stimulation in focal epilepsy2022OPENTitle: Tracking cortical excitability dynamics with transcranial magnetic stimulation in focal epilepsyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 9Issue #: 4Start Page: 540End Page: 551Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51535Best OA location URL: https://doi.org/10.1002/acn3.51535Citation Count: 6
-
OPENTitle: Plasma phosphorylated tau181 predicts cognitive and functional declineJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 10Issue #: 1Start Page: 18End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51695Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51695Citation Count: 29
-
OPENTitle: Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation CarriersJournal Name: Annals of NeurologyPublisher: WileyVol: 91Issue #: 3Start Page: 424End Page: 435Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26302Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8857042Citation Count: 94
- Application of longitudinal item response theory models to modeling Parkinson’s disease progression2022OPENTitle: Application of longitudinal item response theory models to modeling Parkinson’s disease progressionJournal Name: CPT: Pharmacometrics & Systems PharmacologyPublisher: WileyVol: 11Issue #: 10Start Page: 1382End Page: 1392Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/psp4.12853Best OA location URL: https://doi.org/10.1002/psp4.12853Citation Count: 10
-
OPENTitle: Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patientsJournal Name: Clinical and Translational DiscoveryPublisher: WileyVol: 2Issue #: 2Start Page: e96End Page: e96Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/ctd2.96Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ctd2.96Citation Count: 6
-
OPENTitle: Concerns about the European Academy's Recommendations and Guidelines Regarding Pallidotomy for Parkinson's DiseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 30Issue #: 6Start Page: 1831End Page: 1833Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ene.15569Best OA location URL: https://doi.org/10.1111/ene.15569Citation Count: 5
-
OPENTitle: European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapiesJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 9Start Page: 2580End Page: 2595Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1111/ene.15386Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15386Citation Count: 98
- Late Breaking Orals2022OPENTitle: Late Breaking OralsJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 11Issue #: S2Start Page: e12252End Page: e12252Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/jev2.12252Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12252Citation Count: 0
-
OPENTitle: Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 1Start Page: 68End Page: 81Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29257Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/125068Citation Count: 48
-
OPENTitle: Concerns About the European Academy's Recommendations and Guidelines Regarding Pallidotomy for Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 3Start Page: 509End Page: 511Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29210Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29210Citation Count: 3
-
OPENTitle: Split‐Belt Treadmill Training to Improve Gait Adaptation in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 1Start Page: 92End Page: 103Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29238Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29238Citation Count: 20
- Abstracts2022OPENTitle: AbstractsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: S2Start Page: S1End Page: S666Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29223Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29223Citation Count: 40
-
OPENTitle: Disease Progression, Resilience, and Inflammation Markers During the Coronavirus Disease 2019 Pandemic in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2315End Page: 2317Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29212Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29212Citation Count: 5
- Repeat‐Associated Non‐AUG Translation of AGAGGG Repeats that Cause X‐Linked Dystonia‐Parkinsonism2022OPENTitle: Repeat‐Associated Non‐AUG Translation of AGAGGG Repeats that Cause X‐Linked Dystonia‐ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2284End Page: 2289Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29183Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29183Citation Count: 10
-
OPENTitle: Using Downgaze Palsy Progression Rate to Model Survival in Progressive Supranuclear Palsy–Richardson SyndromeJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 304End Page: 312Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29299Best OA location URL: https://doi.org/10.1002/mds.29299Citation Count: 11
- Specialized Versus Generic Allied Health Therapy and the Risk of Parkinson's Disease Complications2022OPENTitle: Specialized Versus Generic Allied Health Therapy and the Risk of Parkinson's Disease ComplicationsJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 223End Page: 231Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29274Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29274Citation Count: 22
-
OPENTitle: Coherent Structural and Functional Network Changes after Thalamic Lesions in Essential TremorJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 9Start Page: 1924End Page: 1929Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29130Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29130Citation Count: 15
-
OPENTitle: The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of LifeJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 291End Page: 301Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28952Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28952Citation Count: 22
-
OPENTitle: Dairy Intake and Parkinson's Disease: A Mendelian Randomization StudyJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 857End Page: 864Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28902Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28902Citation Count: 43
- Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarker2022OPENTitle: Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarkerJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 29Issue #: 10Start Page: 978End Page: 989Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41594-022-00837-0Citation Count: 53
-
OPENTitle: Deep Brain Stimulation for Parkinson’s Disease: Why Earlier Use Makes Shared Decision Making ImportantJournal Name: NeuroethicsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12152-022-09496-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12152-022-09496-w.pdfCitation Count: 4
-
OPENTitle: Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variablesJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 4803End Page: 4809Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-06061-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-06061-4.pdfCitation Count: 35
- Screening performances of an 8-item UPSIT Italian version in the diagnosis of Parkinson’s disease2022OPENTitle: Screening performances of an 8-item UPSIT Italian version in the diagnosis of Parkinson’s diseaseJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 44Issue #: 3Start Page: 889End Page: 895Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-06457-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-06457-2.pdfCitation Count: 8
-
OPENTitle: A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein ToxicityJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 1018End Page: 1036Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s13311-022-01199-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-022-01199-7.pdfCitation Count: 24
-
OPENTitle: The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in EnglandJournal Name: PharmacoEconomicsPublisher: Springer Science and Business Media LLCVol: 40Issue #: 5Start Page: 559End Page: 574Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40273-022-01132-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40273-022-01132-y.pdfCitation Count: 13
-
OPENTitle: Low dose DMSO treatment induces oligomerization and accelerates aggregation of α-synucleinJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 3737End Page: 3737Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-07706-2Best OA location URL: https://www.nature.com/articles/s41598-022-07706-2.pdfCitation Count: 17
-
OPENTitle: Leveraging Patient Preference Information in Medical Device Clinical Trial DesignJournal Name: Therapeutic Innovation & Regulatory SciencePublisher: Springer Science and Business Media LLCVol: 57Issue #: 1Start Page: 152End Page: 159Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s43441-022-00450-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s43441-022-00450-9.pdfCitation Count: 9
-
OPENTitle: The silver linings of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 21End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00283-1Best OA location URL: https://www.nature.com/articles/s41531-022-00283-1.pdfCitation Count: 14